Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HMGCR | P04035 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.30 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.30 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.30 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL592237 | 0.74 | ALDH1A1 (0.40) | ALDH1A1TSHRMEN1CYP1A2KMT2A | |
| SCHEMBL5850679 | 0.74 | FFAR3 (0.35) | ALDH1A1TSHRMEN1CYP1A2KMT2A | |
| SCHEMBL471905 | 0.74 | FFAR3 (0.35) | ALDH1A1TSHRMEN1CYP1A2KMT2A | |
| SCHEMBL3053815 | 0.74 | TSHR (0.40) | ALDH1A1TSHRMEN1CYP1A2KMT2A | |
| SCHEMBL5003423 | 0.72 | TSHR (0.38) | ALDH1A1TSHRMEN1CYP1A2KMT2A | |
| SCHEMBL21269356 | 0.72 | TSHR (0.38) | ALDH1A1TSHRMEN1CYP1A2KMT2A | |
| SCHEMBL21269649 | 0.72 | TSHR (0.38) | ALDH1A1TSHRMEN1CYP1A2KMT2A | |
| SCHEMBL21269186 | 0.72 | TSHR (0.38) | ALDH1A1TSHRMEN1CYP1A2KMT2A | |
| SCHEMBL8043548 | 0.72 | TSHR (0.38) | ALDH1A1TSHRMEN1CYP1A2KMT2A | |
| SCHEMBL1462648 | 0.72 | ALDH1A1 (0.33) | ALDH1A1TSHRMEN1CYP1A2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| US-20100009202-A1 | Surface Treatment of Glass Sheets Prior to Storage | PILKINGTON GROUP LIMITED (GB) | 2010-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100009202-A1 | Surface Treatment of Glass Sheets Prior to Storage | GANAB, GAA, GLA | ALDH1A1 1155/4885TSHR 4200/4885MEN1 2441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.